News & Notes from the Bloom Burton Conference
The Bloom Burton Healthcare Conference in Toronto is an annual pilgrimage for most Canadian life science investors, companies, and service providers. Here are some…
Coverage
Blog
Latest research notes and coverage from the editorial archive.
Delcath, Ocuphire and Perimeter Medical
2022 was a very challenging year for life science investors. At Encode, we struggled mightily to stay positive and optimistic about the sector. Conversations…
Xenon Pharma
Of all the names in our coverage universe Xenon (Nasdaq: XENE) has been the most resilient during one of the bleakest biotech tapes in…
Modular Medical
Modular Medical (Nasdaq: MODD) has had an eventful 1H22. The company raised $23mm through two transactions, uplisted to Nasdaq, and appointed its largest institutional…
Ocuphire Pharma
Over the coming weeks we will be providing updates on many of the companies within our coverage universe. We recognize market sentiment, especially in…
Manchester Management
An interview with Jeb Besser, Managing Member at Manchester Management, a $100M AUM hedge fund that makes concentrated investments in micro/small cap health care…
Social Capital LP
In January 2022, Social Capital made a C$43.4 million strategic investment in Perimeter Medical Imaging AI (TSX-V: PINK, US: PYNKF) to advance Perimeter’s ultra-high-resolution,…
Rosalind Advisors
An interview with Gil Aharon of Rosalind Advisors, where we discuss his perspective on the macro biotech market. Having run a dedicated life science…
Findell Capital
An interview with Brian Finn, Founder and CIO of Findell Capital, where we discuss his perspective on small-cap investing. Findell Capital is a ~65mm…
George W. Haywood
An interview with George Haywood, a well-known investor, where we discuss his perspective on biotech investing. During the interview, we cover some of George’s…